The healthcare landscape for diabetes is shifting, and these patches represent a potential development. Unlike subcutaneous injections, this method offers a simpler way to administer GLP-1 drugs. These transdermal systems steadily release the treatment through the skin offering a even amount of the beneficial agent, which can enhance glucose contro